153 related articles for article (PubMed ID: 28286599)
1. Cardiovascular biomarkers and their utility in the older adult.
Bell SP; Giuseffi JL; Forman DE
Curr Cardiovasc Risk Rep; 2012 Oct; 6(5):397-403. PubMed ID: 28286599
[TBL] [Abstract][Full Text] [Related]
2. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
Krintus M; Kozinski M; Kubica J; Sypniewska G
Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification in very old adults: how to best gauge risk as the basis of management choices for patients aged over 80.
Bell SP; Saraf A
Prog Cardiovasc Dis; 2014; 57(2):197-203. PubMed ID: 25216619
[TBL] [Abstract][Full Text] [Related]
4. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.
Billups KL; Miner MM; Wierzbicki AS; Jackson G
Int J Clin Pract; 2011 Feb; 65(2):134-47. PubMed ID: 21199197
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine.
Wu IC; Lin CC; Hsiung CA
Biomedicine (Taipei); 2015; 5(1):1. PubMed ID: 25722960
[TBL] [Abstract][Full Text] [Related]
6. Vascular risk assessment in older adults without a history of cardiovascular disease.
Bambrick P; Tan WS; Mulcahy R; Pope GA; Cooke J
Exp Gerontol; 2016 Jun; 79():37-45. PubMed ID: 26972634
[TBL] [Abstract][Full Text] [Related]
7. Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factors.
Solow EB; Vongpatanasin W; Skaug B; Karp DR; Ayers C; de Lemos JA
Clin Exp Rheumatol; 2018; 36(6):1031-1037. PubMed ID: 30299240
[TBL] [Abstract][Full Text] [Related]
8. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
[TBL] [Abstract][Full Text] [Related]
9. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives.
Forman DE; de Lemos JA; Shaw LJ; Reuben DB; Lyubarova R; Peterson ED; Spertus JA; Zieman S; Salive ME; Rich MW;
J Am Coll Cardiol; 2020 Sep; 76(13):1577-1594. PubMed ID: 32972536
[TBL] [Abstract][Full Text] [Related]
11. Circulating biomarkers for the diagnosis and prognosis of heart failure.
Tousoulis D; Kampoli AM; Siasos G; Stefanadi E; Antoniades C; Papavassiliou AG; Stefanadis C
Curr Med Chem; 2009; 16(29):3828-40. PubMed ID: 19747138
[TBL] [Abstract][Full Text] [Related]
12. Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach.
Waziry R; Gras L; Sedaghat S; Tiemeier H; Weverling GJ; Ghanbari M; Klap J; de Wolf F; Hofman A; Ikram MA; Goudsmit J
Eur J Epidemiol; 2019 Aug; 34(8):793-799. PubMed ID: 30993509
[TBL] [Abstract][Full Text] [Related]
13. Interactions between C-reactive protein and traditional risk factors in predicting mortality of older adults.
Rudolf H; Wall N; Klaassen-Mielke R; Thiem U; Diehm C; Trampisch HJ; Krause D
Vasa; 2017 Mar; 46(2):127-133. PubMed ID: 28102774
[TBL] [Abstract][Full Text] [Related]
14. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Cummings DM; King DE; Mainous AG; Geesey ME
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
16. Multiple biomarker strategies for risk stratification in heart failure.
Bayes-Genis A; Ordonez-Llanos J
Clin Chim Acta; 2015 Mar; 443():120-5. PubMed ID: 25451945
[TBL] [Abstract][Full Text] [Related]
17. Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.
Rich MW; Chyun DA; Skolnick AH; Alexander KP; Forman DE; Kitzman DW; Maurer MS; McClurken JB; Resnick BM; Shen WK; Tirschwell DL;
Circulation; 2016 May; 133(21):2103-22. PubMed ID: 27067230
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study.
Graversen P; Abildstrøm SZ; Jespersen L; Borglykke A; Prescott E
Eur J Prev Cardiol; 2016 Sep; 23(14):1546-56. PubMed ID: 26976846
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
